LENZ Therapeutics, Inc./$LENZ
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About LENZ Therapeutics, Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
Ticker
$LENZ
Sector
Primary listing
Employees
-
Headquarters
Website
LENZ Metrics
BasicAdvanced
$828M
-
-$2.11
-
-
Price and volume
Market cap
$828M
52-week high
$50.40
52-week low
$16.54
Average daily volume
1.1M
Financial strength
Current ratio
12.687
Quick ratio
12.458
Long term debt to equity
0.238
Total debt to equity
0.492
Profitability
EBITDA (TTM)
-67.695
Gross margin (TTM)
100.00%
Net profit margin (TTM)
-336.47%
Operating margin (TTM)
-388.00%
Effective tax rate (TTM)
-0.86%
Management effectiveness
Return on assets (TTM)
-19.52%
Return on equity (TTM)
-28.78%
Valuation
Price to revenue (TTM)
42.205
Price to book
3.9
Price to tangible book (TTM)
3.9
Price to free cash flow (TTM)
-16
Free cash flow yield (TTM)
-6.25%
Free cash flow per share (TTM)
-1.653
Growth
Earnings per share change (TTM)
-48.37%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for LENZ Therapeutics, Inc. stock?
LENZ Therapeutics, Inc. (LENZ) has a market cap of $828M as of December 11, 2025.
What is the P/E ratio for LENZ Therapeutics, Inc. stock?
The price to earnings (P/E) ratio for LENZ Therapeutics, Inc. (LENZ) stock is 0 as of December 11, 2025.
Does LENZ Therapeutics, Inc. stock pay dividends?
No, LENZ Therapeutics, Inc. (LENZ) stock does not pay dividends to its shareholders as of December 11, 2025.
When is the next LENZ Therapeutics, Inc. dividend payment date?
LENZ Therapeutics, Inc. (LENZ) stock does not pay dividends to its shareholders.
What is the beta indicator for LENZ Therapeutics, Inc.?
LENZ Therapeutics, Inc. (LENZ) does not currently have a Beta indicator.